Gilead Sciences to Present at Two Upcoming Investor Conferences

- 20th Annual Piper Jaffray Health Care Conference on December 2nd -
FOSTER CITY, Calif., Nov 25, 2008 (BUSINESS WIRE) -- --- NASDAQ OMX 22nd Investor Program on December 4th -

--- Webcasts Available Through Gilead Corporate Website -

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: the 20th Annual Piper Jaffray Health Care Conference in New York and the NASDAQ OMX 22nd Investor Program in London. These webcasts may be accessed via the company's corporate website at

John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will provide an overview of the company at the Piper Jaffray conference on Tuesday, December 2 at 9:30 a.m. Eastern Standard Time (EST).

Kevin Young, Gilead's Executive Vice President of Commercial Operations, will provide an overview of the company at the NASDAQ OMX Investor Program on Thursday, December 4 at 3:15 p.m. Greenwich Mean Time (10:15 a.m. EST).

To access the live webcasts via the internet log on to Please connect to the company's website at least 15 minutes prior to each live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

SOURCE: Gilead Sciences, Inc.

Gilead Sciences, Inc.
Susan Hubbard, 650-522-5715 (Investor Relations)